NEUVAX Trademark

Trademark Overview

On Monday, April 16, 2018, a trademark application was filed for NEUVAX with the United States Patent and Trademark Office. The USPTO has given the NEUVAX trademark a serial number of 87878311. The federal status of this trademark filing is REGISTERED as of Tuesday, January 18, 2022. This trademark is owned by SELLAS Life Sciences Group, Inc.. The NEUVAX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and vaccines for the treatment of cancer
neuvax

General Information

Serial Number87878311
Word MarkNEUVAX
Filing DateMonday, April 16, 2018
Status700 - REGISTERED
Status DateTuesday, January 18, 2022
Registration Number6622822
Registration DateTuesday, January 18, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 11, 2018

Trademark Statements

Goods and ServicesPharmaceutical preparations and vaccines for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 23, 2018
Primary Code005
First Use Anywhere DateThursday, December 31, 2015
First Use In Commerce DateThursday, December 31, 2015

Trademark Owner History

Party NameSELLAS Life Sciences Group, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNew York, NY 10036
Party NameSELLAS Life Sciences Group, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10036
Party NameSELLAS Life Sciences Group, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10017

Trademark Events

Event DateEvent Description
Tuesday, January 18, 2022REGISTERED-PRINCIPAL REGISTER
Saturday, December 11, 2021NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, December 10, 2021ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, October 27, 2021STATEMENT OF USE PROCESSING COMPLETE
Thursday, October 21, 2021USE AMENDMENT FILED
Thursday, October 21, 2021TEAS STATEMENT OF USE RECEIVED
Wednesday, April 28, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 27, 2021EXTENSION 5 GRANTED
Tuesday, April 13, 2021EXTENSION 5 FILED
Tuesday, April 27, 2021CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 13, 2021TEAS EXTENSION RECEIVED
Thursday, November 5, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, November 3, 2020EXTENSION 4 GRANTED
Tuesday, November 3, 2020EXTENSION 4 FILED
Tuesday, November 3, 2020TEAS EXTENSION RECEIVED
Thursday, April 9, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, April 7, 2020EXTENSION 3 GRANTED
Tuesday, April 7, 2020EXTENSION 3 FILED
Tuesday, April 7, 2020TEAS EXTENSION RECEIVED
Saturday, October 19, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 17, 2019EXTENSION 2 GRANTED
Thursday, October 17, 2019EXTENSION 2 FILED
Thursday, October 17, 2019TEAS EXTENSION RECEIVED
Wednesday, May 8, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 6, 2019EXTENSION 1 GRANTED
Monday, May 6, 2019EXTENSION 1 FILED
Monday, May 6, 2019TEAS EXTENSION RECEIVED
Tuesday, November 6, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 11, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 11, 2018PUBLISHED FOR OPPOSITION
Wednesday, August 22, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Saturday, August 4, 2018APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 3, 2018ASSIGNED TO EXAMINER
Monday, April 23, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 19, 2018NEW APPLICATION ENTERED IN TRAM

Related Keywords

neuvax cancer treatment vaccines preparations pharmaceutical